July 30, 2014 

Drug Enforcement Administration 

Attention: DEA Federal Register Representative/ODW 

8701 Morrissette Drive 

Springfield, VA 22152 

Subject: Docket No. DEA-393 

Dear Sirs: 

CONFIDENTIAL 

I, William C. Miller of Johnson Matthey Inc., Pharmaceutical Materials, manufacturing 

registration 007082JNX, am submitting this comment on the 2015 Proposed Aggregate 

Production Quota for various products as published in the July 2, 2014 Federal Register. We 

consider the information in this first paragraph to be "PERSONAL IDENTIFYING 

INFORMATION" and this information should not be released under the Freedom of Information 

Act per 5 USC Sec. 552(b)(4). In addition, the following information is "CONFIDENTIAL 

BUSINESS INFORMATION". The following items' List I import quota should be increased by 

the identified quantity: (i) Phenylpropanolamine (for conversion) by 2,000,000 grams as base. 

This number is over and above the volumes identified in our late April 2014 requests for 2015. 

As noted herein, this first paragraph of this letter contains personal identifying and confidential 

business information and should be redacted in its entirety from any public docket. 

We feel the proposed quantities for the material mentioned above are not sufficient to provide for 

adequate supplies for the medical, scientific, research and industrial needs of the United States, 

and for the lawful export requirements, and that the quotas should be increased to cover our 

needs. For these items an appropriate Electronic DEA Quota Application Form 488 has been 

submitted pertaining to the items for which we are submitting comments. 

Very truly yours 
July 30, 2014 

Drug Enforcement Administration 

Attention: DEA Federal Register Representative/ODW 

8701 Morrissette Drive 

Springfield, VA 22152 

Subject: Docket No. DEA-393 

Dear Sirs: 

CONFIDENTIAL 

I, William C. Miller of Johnson Matthey Inc., Pharmaceutical Materials, manufacturing 

registration RJ0413322, am submitting this comment on the 2015 Proposed Aggregate 

Production Quota for various products as published in the July 2, 2014 Federal Register. We 

consider the information in this first paragraph to be "PERSONAL IDENTIFYING 

INFORMATION" and this information should not be released under the Freedom of Information 

Act per 5 USC Sec. 552(b)(4). In addition, the following information is "CONFIDENTIAL 

BUSINESS INFORMATION". The following items' manufacturing quota should be increased 

by the identified quantity: (i) Codeine (for conversion) by 15,940,000 grams as base; and (ii) 

Oxycodone (for sale) by 1,800,000 grams as base. These numbers are over and above the 

volumes identified in our late April 2014 requests for 2015. As noted herein, this first paragraph 

of this letter contains personal identifying and confidential business information and should be 

redacted in its entirety from any public docket. 

We feel the proposed quantities for the material mentioned above are not sufficient to provide for 

adequate supplies for the medical, scientific, research and industrial needs of the United States, 

and for the lawful export requirements, and that the quotas should be increased to cover our 

needs. For these items an appropriate Electronic DEA Quota Application Form 189 has been 

submitted pertaining to the items for which we are submitting comments. 

Very truly yours 
July 30, 2014 

Drug Enforcement Administration 

Attention: DEA Federal Register Representative/ODW 

8701 Morrissette Drive 

Springfield, VA 22152 

Subject: Docket No. DEA-393 

Dear Sirs: 

CONFIDENTIAL 

I, William C. Miller of Johnson Matthey Inc., Pharmaceutical Materials, manufacturing 

registration RJO 100987, am submitting this comment on the 2015 Proposed Aggregate 

Production Quota for various products as published in the July 2, 2014 Federal Register. We 

consider the information in this first paragraph to be "PERSONAL IDENTIFYING 

INFORMATION" and this information should not be released under the Freedom of Information 

Act per 5 USC Sec. 552(b)(4). In addition, the following information is "CONFIDENTIAL 

BUSINESS INFORMATION". The following items' manufacturing quota should be increased 

by the identified quantity: (i) Alfentanil by 1,780 grams as base; (ii) Amphetamine (for sale) by 

455,000 grams as base [225,000 grams is D,L-Amphetamine and 230,000 grams is DAmphetamine]; (iii) Codeine (for sale) by 74,000 grams as base; (iv) Dihydromorphine by 

250,000 grams as base; (v) Diphenoxylate by 3,750 grams as base, (vi) Fentanyl by 125,000 

grams as base; (vii) Hydrocodone (for sale) by 610,000 grams as base; (viii) Hydromorphone by 

178,000 grams as base; (ix) Methamphetamine (for sale) by 2,400 grams as base; (x) Oxycodone 

(for sale) by 1,350,000 grams as base; (xi) Sufentanil by 860 grams as base; (xii) Tapentadol by 

40,000 grams as base; and Tetrahydrocannabinols by 10,000 grams as base. These numbers are 

over and above the volumes identified in our late April 2014 requests for 2015 . As noted herein, 

this first paragraph of this letter contains personal identifying and confidential business 

information and should be redacted in its entirety from any public docket. 

We feel the proposed quantities for the material mentioned above are not sufficient to provide for 

adequate supplies for the medical, scientific, research and industrial needs of the United States, 

and for the lawful export requirements, and that the quotas should be increased to cover our 

needs. For these items an appropriate Electronic DEA Quota Application Form 189 will be 

submitted shortly pertaining to the items for which we are submitting comments. 

Very truly yours 
.... .,, ........ ""'"'tJ'- ...

--·-

ups.com® or call 1-800-PICK-IJl"'"""" 

v ::1 L .:S"t 

1 ... ""-'-

' ,...' 

or 

'-

-, 

I '° 

/ i --. 

I 

Is I;· 

! 

-·, 

· .. , I 

h J ' 

near you. , . 

, _

UPS Next Day Air{i) 

UPS Worldwide Express'•) 

tI( ... 

i E 853 

fv'\ I, \ l SVH 

JOHNSON MATIHEY tlOZ l E lnr 

2003 NOL TE DRIVE 17#; (]3J\1303fl 

WEST DEPTFORD NJ 08066 

... """ ... 

D 

[ 

I Shipping Notice - Carriage hereunder may be subject to the rules relating to liability and other terms and/or conditions established by the Convention f

the International Carriage of Goods by Road (the ' CMR Convention' ). These commodities, technology or software were exported lrom the U.S. in accorda